Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston
3
×
boston blog main
boston top stories
genentech
3
×
life sciences
national blog main
national top stories
roche
san francisco blog main
avapritinib
blueprint medicines
cancer
deals
eli lilly
fda
medullary thyroid cancer
non-small cell lung cancer
pralsetinib
san francisco top stories
selpercatinib
thyroid cancer
cancer drugs
cancer immunotherapy
capmatinib
center for medicare and medicaid services
clinical trials
companion diagnostic
cstone pharmaceuticals
daniel o'day
europe blog main
europe top stories
european medicines agency
fisogatinib
flatiron health
foundation medicine
foundationone cdx
foundationone heme
gastrointestinal stromal tumors
hepatocellular carcinoma
What
approval
blueprint
cancer
drug
fda
medicines
ret
roche
acquire
address
agreed
approves
big
billion
broad
candidate
carries
certain
confidence
currently
designed
didn’t
foundation
gain
genentech
genetic
latest
marketing
medicine
momentum
morning
muscle
pact
panels
pass
pay
pays
picked
profiling
recently
Language
unset
Current search:
boston
×
genentech
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine